BioCentury | Apr 15, 2013
Company News

HemaSure, In-Line Diagnostics, American Red Cross deal

...of the technology in blood banking. The Red Cross and In-Line will aid in development. HemaSure Inc....
BioCentury | Apr 15, 2013
Clinical News

HemaSure regulatory update

...filtration technology to areas such as tumor cells, cord blood, whole blood, platelets and plasma. HemaSure Inc....
BioCentury | Nov 19, 2001
Company News

HMSR Inc., Point Therapeutics deal

...hematopoietic cells to treat neutropenia in cancer patients undergoing chemotherapy. Earlier this year, HMSR, formerly HemaSure...
BioCentury | Oct 15, 2001
Company News

Whatman Hemasure plc, Pall blood products/substitutes news

...the U.S. Court of Appeals for the Federal Circuit (see BioCentury, June 14, 1999). Whatman Hemasure...
BioCentury | Jun 4, 2001
Company News

HemaSure, Whatman deal

...the assets of blood filtration company HMSR, except for HMSR's cash (see BioCentury, Feb. 12). HemaSure Inc....
BioCentury | Feb 12, 2001
Finance

Ebb & Flow

...company Whatman (LSE:WHM) fell 20p to 247.5p after saying it will acquire the assets of HemaSure...
BioCentury | Feb 12, 2001
Company News

Whatman management update

...Supply/Service Hired: Jack McGuire as head of Whatman BioScience, formerly president and chief executive of HemaSure Inc. WIR...
BioCentury | Feb 12, 2001
Company News

HemaSure, Whatman deal

...in cash and WHM stock and will consider merger or other options for its business. HemaSure Inc....
BioCentury | Feb 5, 2001
Company News

Whatman to buy HemaSure

Whatman (LSE:WHM), a separations technology company, will acquire the assets of blood filtration company HMSR, except for HMSR's cash, for about $13 million, including $10 million in cash and $3 million in cash or stock....
BioCentury | Oct 2, 2000
Company News

HemaSure, American Red Cross deal

...reactions in patients who received blood transfusions filtered with the system (see BioCentury, April 17). HemaSure Inc....
Items per page:
1 - 10 of 66
BioCentury | Apr 15, 2013
Company News

HemaSure, In-Line Diagnostics, American Red Cross deal

...of the technology in blood banking. The Red Cross and In-Line will aid in development. HemaSure Inc....
BioCentury | Apr 15, 2013
Clinical News

HemaSure regulatory update

...filtration technology to areas such as tumor cells, cord blood, whole blood, platelets and plasma. HemaSure Inc....
BioCentury | Nov 19, 2001
Company News

HMSR Inc., Point Therapeutics deal

...hematopoietic cells to treat neutropenia in cancer patients undergoing chemotherapy. Earlier this year, HMSR, formerly HemaSure...
BioCentury | Oct 15, 2001
Company News

Whatman Hemasure plc, Pall blood products/substitutes news

...the U.S. Court of Appeals for the Federal Circuit (see BioCentury, June 14, 1999). Whatman Hemasure...
BioCentury | Jun 4, 2001
Company News

HemaSure, Whatman deal

...the assets of blood filtration company HMSR, except for HMSR's cash (see BioCentury, Feb. 12). HemaSure Inc....
BioCentury | Feb 12, 2001
Finance

Ebb & Flow

...company Whatman (LSE:WHM) fell 20p to 247.5p after saying it will acquire the assets of HemaSure...
BioCentury | Feb 12, 2001
Company News

Whatman management update

...Supply/Service Hired: Jack McGuire as head of Whatman BioScience, formerly president and chief executive of HemaSure Inc. WIR...
BioCentury | Feb 12, 2001
Company News

HemaSure, Whatman deal

...in cash and WHM stock and will consider merger or other options for its business. HemaSure Inc....
BioCentury | Feb 5, 2001
Company News

Whatman to buy HemaSure

Whatman (LSE:WHM), a separations technology company, will acquire the assets of blood filtration company HMSR, except for HMSR's cash, for about $13 million, including $10 million in cash and $3 million in cash or stock....
BioCentury | Oct 2, 2000
Company News

HemaSure, American Red Cross deal

...reactions in patients who received blood transfusions filtered with the system (see BioCentury, April 17). HemaSure Inc....
Items per page:
1 - 10 of 66